Denosumab for osteoporosis reduces incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared to bisphosphonates: an analysis of real-world, cohort data, with a systematic review and meta-analysis.

Alex E. Henney, David R. Riley, Ben O’Connor, Theresa J. Hydes, Matthew Anson , Sizheng Steven Zhao, Uazman Alam, Daniel J. Cuthbertson

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Denosumab for osteoporosis reduces incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared to bisphosphonates: an analysis of real-world, cohort data, with a systematic review and meta-analysis.'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science